 |
Rastegar Epigenetics & Neural Stem Cell Lab |
|
Rastegar Epigenetics & Neural Stem Cell Lab |
| Publications |
||||
| Rastegar M., Hotta A., Pasceri P.,
Makarem M., Cheung A., Elliot S., Adachi M., Jones, F.S., Park K.J.,
Clarke I., Dirks P. and Ellis J. MECP2 Isoform-Specific Vectors with
Regulated Expression for Rett Syndrome Gene Therapy. (2009) PLoS ONE.
In Press Delcuve G.P., Rastegar M. and Davie JR. Epigenetic Control. (2009) J. Cell. Physiol. 219 (2): 243-50 Ellis J., Hotta A., and Rastegar M. Retrovirus Silencing by an Epigenetic TRIM. (2007) Cell. 131(1): 13-14 Nolte C.*, Rastegar M.*, Amores A., Bouchard M., Grote D., Maas R., Nagy Kovacs E., Postlethwait J., Rambaldi I., Rowan Sh., Zhang F., and Featherstone M. Stereospecificity and PAX6 function direct Hoxd4 neural enhancer activity along the antero-posterior axis. Dev Biol. (2006) 15-299(2): 582-93 *equal first authorship Kobrossy L., Rastegar M., and Featherstone M. Interplay between chromatin and trans-acting factors regulating the Hoxd4 promoter during neural differentiation. (2006) J Biol Chem. 281:25926-39 Huang H., Rastegar M., Bodner C., Goh S. L, Rambaldi I., and Featherstone M. Meis C-termini harbor transcriptional activation domains that respond to cell signaling. (2005) J Biol Chem. 280:10119-27 Rastegar M., Kobrossy L., Nagy Kovàcs E., Rambaldi I., and Featherstone M. Sequential histone modifications at Hoxd4 regulatory regions distinguish anterior from posterior embryonic compartments. (2004) Mol Cell Biol. 24: 8090-8103 Gordon J., Wu C.H., Rastegar M., and Safa A.R. 2-microglobulin induces caspase-dependent apoptosis in CCRF-HBS-2 human leukemia cell line independently of caspase-3, -8, and -9 pathways but through increased reactive oxygen species. Int J Cancer. (2003) 103: 316-327 Wu C.H., Gordon J., Rastegar M., Ogretmen B., and Safa A.R. Proteinase-3, a serine protease which mediates doxorubicin-induced apoptosis in the HL-60 leukemia cell line is down-regulated in its doxorubicin-resistant variant. Oncogene. (2002) 21: 5160-5174 Wu C.H., Rastegar M., Gordon J. and Safa A.R. 2-microglobulin induces apoptosis in HL-60 human leukemia cells and its multidrug resistant variants overexpressing MRP1 but lacking Bax or overexpressing P- glycoprotein. Oncogene. (2001) 25: 7006-7020 Rastegar M., Rousseau G.G. and Lemaigre F.P. CCAAT/Enhancer Binding Protein alpha (C/EBP ) is a mediator of growth hormone action in the liver and controls the expression of Hepatocyte Nuclear Factor-6 (HNF-6). Endocrinology. (2000) 141: 1686-92 Lahuna O.*, Rastegar M.*, Maiter D., Thissen J.-P., Lemaigre F.P. and Rousseau G.G. Involvement of STAT5 and HNF-4 in the transcriptional control of the hnf6 gene by growth Hormone. Mol Endocrinol. (2000) 14: 285-94 *equal first authorship Rastegar M., Lemaigre F.P. and Rousseau G.G. Control of gene expression by growth hormone in liver: Key role of a network of transcription factors. Mol Cell Endocrinol. (2000) 164: 1-4 Rastegar M., Lemaigre F.P. and Rousseau G.G. HNF-6: Pièce maîtresse d’un réseau de facteurs de transcription hépatiques contrôlé par l’hormone de croissance. Médicine/Sciences. (2000) 16: 1106-1108 Rastegar M., Szpirer C., Rousseau G.G. and Lemaigre F. P. Hepatocyte nuclear factor 6: organization and chromosomal assignment of the rat gene and characterization of its promoter. Biochem J. (1998) 334: 565-569 |
Home |
|||
| Current
Projects |
||||
| Lab
Personnel |
||||
| Publications |
||||
| Contact |
||||
| Links |
||||
| Positions Available |
||||
| Copyright © 2010
Mojgan Rastegar. All rights reserved. Site Design by Skye Rousseau. |